Medidata builds open-source connector to link cloud with Apple’s ResearchKit

By Zachary Brennan contact

- Last updated on GMT

Medidata builds open-source connector to link cloud with Apple

Related tags: Clinical trial

Cloud-based tool provider Medidata has built an open-source connector linking the new Apple ResearchKit with its cloud to enable biopharma companies, CROs and academic institutions to map data generated by ResearchKit apps.

Medidata has released the source code for the connector on GitHub, the world’s largest open source community, enabling researchers to create connections between ResearchKit apps and the Medidata platform.

ResearchKit, Apple’s open-source framework, enables developers and researchers to create apps for medical research and brings together sets of personal data from iOS apps.

Kara Dennis, Managing Director, mHealth at Medidata, told Outsourcing-Pharma.com:"There is a strong level of interest among our customer base to use ResearchKit apps to help collect in-life data in clinical trials. However, many clients aren’t yet sure of what it would take to successfully accomplish this from an operational, technological and regulatory standpoint. That’s why the connector we have built is so important. We can show life sciences companies very clearly that there is a path forward to bringing ResearchKit apps into the highly controlled, regulated world of clinical trials. 

To further the impact that this data can have in clinical research, Medidata has developed a mechanism allowing study builders to map the data generated from ResearchKit apps to studies in Medidata’s electronic data capture system.

The new connector, which Medidata did not work on with Apple, is part of Medidata’s ongoing efforts to unify mobile health devices with cloud-based technologies in a clinical trial setting.

"This integration—like the ones we have developed for other mHealth data sources such as Garmin, Fitbit and Vital Connect—enable customers to use the Medidata platform to manage all their streams of clinical trial data, resulting in a unified clinical record," ​Matthew Noble, Senior Director, Product Management told us.

Related news

Show more

Related products

show more

The APAC Advantages

The APAC Advantages

Catalent Pharma Solutions | 18-Jan-2022 | Insight Guide

Over recent years, the Asia-Pacific (APAC) region has become an emerging market for pharmaceutical and biotech innovation, including clinical studies.

Optimizing Processes for Modern Digital Trials

Optimizing Processes for Modern Digital Trials

eClinical Solutions | 12-Jan-2022 | Case Study

Modern digital trials have sparked a new need within life sciences organizations for optimized and scalable clinical data processes & strategies. This...

The Case for a Clinical Data Strategy

The Case for a Clinical Data Strategy

eClinical Solutions | 12-Jan-2022 | Technical / White Paper

Being data-driven is top-of-mind for many life sciences companies, but actually turning that idea into action is easier said than done. To effectively...

Related suppliers

Follow us


View more